Latest & greatest articles for side effects

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on side effects or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on side effects and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for side effects

21. Domperidone: risks of cardiac side effects

Domperidone: risks of cardiac side effects Domperidone: risks of cardiac side effects Drug Safety Update - GOV.UK GOV.UK uses cookies to make the site simpler. Search Domperidone: risks of cardiac side effects From: Published: 30 May 2014 Therapeutic area: and Indication restricted to nausea and vomiting, new contraindications, and reduced dose and duration of use. Article date: May 2014 Domperidone is a dopamine antagonist with antiemetic properties. A European review assessed the benefits (...) and risks of domperidone following continued reports of cardiac side effects. The review confirmed a small increased risk of serious cardiac side effects. A higher risk was observed particularly in people older than 60 years, people taking daily oral domperidone doses of more than 30 mg, and those taking QT-prolonging medicines or CYP3A4 inhibitors at the same time as domperidone. For indications other than nausea and vomiting, the benefits were not considered to outweigh the cardiac risk. Based

MHRA Drug Safety Update2014

22. Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects

Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects Drug Safety Update - GOV.UK GOV.UK uses cookies to make the site simpler. Search Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects From: Published: 19 December 2014 Therapeutic area: New advice to minimise risk Ivabradine (Procoralan) is used to treat chronic heart

MHRA Drug Safety Update2014

23. Paliperidone depot is not different from haloperidol in relapse prevention of schizophrenia, but different side effects should be considered

Paliperidone depot is not different from haloperidol in relapse prevention of schizophrenia, but different side effects should be considered Paliperidone depot is not different from haloperidol in relapse prevention of schizophrenia, but different side effects should be considered | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Paliperidone depot is not different from haloperidol in relapse prevention of schizophrenia, but different side effects should be considered Article Text Pharmacological interventions Paliperidone depot

Evidence-Based Mental Health2014

24. Randomised controlled trial: Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects

Randomised controlled trial: Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects Article

Evidence-Based Medicine (Requires free registration)2014

25. Is folate effective for methotrexate side effects?

Is folate effective for methotrexate side effects? Is folate effective for methotrexate side effects? » Morsels of Evidence Search Evidence based medicine for general practitioners « » Sep 06 Is folate effective for methotrexate side effects? Categories: , by Journal reference: Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis (...) . Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD000951 Link: Published: 31 May 2013 Evidence cookie says… L ow dose folic acid (≤ 7 mg/week) substantially reduces the likelihood of certain side-effects of methotrexate in patients with rheumatoid arthritis. This appears to be very clinically significant – NNT of 7 for one patient not to withdraw from MTX therapy. Low dose folic acid did not appear to reduce the effectiveness of MTX. Clinical scenario Penny, a 55-year old lady

Morsels of Evidence2013

26. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. BACKGROUND: Methotrexate (MTX) is a disease modifying antirheumatic drug (DMARD) used as a first line agent for treating rheumatoid arthritis (RA). Pharmacologically, it is classified as an antimetabolite due to its antagonistic effect on folic acid metabolism. Many patients treated with MTX experience mucosal, gastrointestinal, hepatic or haematologic side effects. Supplementation (...) with folic or folinic acid during treatment with MTX may ameliorate these side effects. OBJECTIVES: To identify trials of supplementation with folic acid or folinic acid during MTX therapy for rheumatoid arthritis and to assess the benefits and harms of folic acid and folinic acid (a) in reducing the mucosal, gastrointestinal (GI), hepatic and haematologic side effects of MTX, and (b) whether or not folic or folinic acid supplementation has any effect on MTX benefit. SEARCH METHODS: We originally

Cochrane2013

27. Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons Haddad PM, Das A, Keyhani S, Chaudhry IB CRD summary This review concluded that second generation antipsychotics offer (...) , Chaudhry IB. Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons. Journal of Psychopharmacology 2012; 26(5 Supplement): 15-26 PubMedID DOI Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Antipsychotic Agents /adverse effects /therapeutic use; Basal Ganglia Diseases /chemically induced; Dyskinesia, Drug-Induced /diagnosis; Humans; Psychotic Disorders /drug therapy AccessionNumber 12012043369 Date

DARE.2013

28. Systematic review with meta-analysis: Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS

Systematic review with meta-analysis: Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS Article Text

Evidence-Based Medicine (Requires free registration)2013

29. Mefloquine: strengthened warnings on neuropsychiatric side effects

Mefloquine: strengthened warnings on neuropsychiatric side effects Mefloquine: strengthened warnings on neuropsychiatric side effects Drug Safety Update - GOV.UK GOV.UK uses cookies to make the site simpler. Search Mefloquine: strengthened warnings on neuropsychiatric side effects From: Published: 14 November 2013 Therapeutic area: , , and A recent review of the prescribing information has led to strengthened warnings and new measures to help minimise risks. To minimise the risk (...) : November 2013 Mefloquine (brand name Lariam) is used for prophylaxis and treatment of Plasmodium falciparum malaria. Official guidance on the appropriate use of antimalarial medicines and the prevalence of resistance should be considered when prescribing mefloquine (see further information links below). Although the potential for neuropsychiatric side effects with mefloquine is a well-established risk, a recent review of the prescribing information has led to strengthened warnings and new measures

MHRA Drug Safety Update2013

30. No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics

No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics Article Text Therapeutics No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics Statistics from Altmetric.com No Altmetric data available

Evidence-Based Mental Health2012

31. Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs

Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword (...) Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs Article Text Therapeutics Review: extrapyramidal side effects vary between different second-generation antipsychotic drugs Statistics from Altmetric.com No Altmetric data available for this article. Question

Evidence-Based Mental Health2012

32. No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ

No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password (...) ? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ Article Text Therapeutics No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ Statistics from Altmetric.com

Evidence-Based Mental Health2011

33. Review: metabolic side effects of second-generation antipsychotics

Review: metabolic side effects of second-generation antipsychotics Review: metabolic side effects of second-generation antipsychotics | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: metabolic side effects of second-generation antipsychotics Article Text Therapeutics Review: metabolic side effects of second-generation antipsychotics Statistics from Altmetric.com No Altmetric data available for this article. Question Question To what extent do second-generation antipsychotics (SGAs) cause metabolic side effects? Outcomes Primary : weight change

Evidence-Based Mental Health2011

34. Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported reasons

Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported reasons Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported reasons | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your (...) user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported reasons Article Text Prevalence Antidepressant non-adherence is common among veterans, with ineffectiveness and side effects as commonly reported

Evidence-Based Mental Health2011

35. Anti-epileptic drugs: how they treat seizures and their unwanted side-effects

Anti-epileptic drugs: how they treat seizures and their unwanted side-effects ERROR: Literature could not be found.

Tuberous Sclerosis Association2011

37. Patients with cancer believed that chemotherapy had to ?hurt? or ?cause side effects? to be effective

Patients with cancer believed that chemotherapy had to ?hurt? or ?cause side effects? to be effective Patients with cancer believed that chemotherapy had to “hurt” or “cause side effects” to be effective | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password (...) ? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Patients with cancer believed that chemotherapy had to “hurt” or “cause side effects” to be effective Article Text Qualitative Patients with cancer believed that chemotherapy had to “hurt” or “cause side effects” to be effective Statistics from Altmetric.com

Evidence-Based Nursing (Requires free registration)2010

39. Incisional continuous fascia iliaca block provides more effective pain relief and fewer side effects than opioids after pelvic osteotomy in children

Incisional continuous fascia iliaca block provides more effective pain relief and fewer side effects than opioids after pelvic osteotomy in children 19923505 2009 11 20 2009 12 03 2013 11 21 1526-7598 109 6 2009 Dec Anesthesia and analgesia Anesth. Analg. Incisional continuous fascia iliaca block provides more effective pain relief and fewer side effects than opioids after pelvic osteotomy in children. 1799-803 10.1213/ANE.0b013e3181bbc41a Intravenous opioid therapy is frequently used (...) for postoperative pain management in children after orthopedic surgery but causes side effects such as respiratory depression, vomiting, sedation, and urinary retention. To investigate whether a continuous incisional fascia iliaca compartment (FIC) block provides more effective postoperative pain relief with fewer side effects than IV morphine, we performed a prospective, double-blind, randomized study to compare both techniques. Thirty children (ASA physical status I-II) aged 3 mo to 6 yr undergoing a pelvic

EvidenceUpdates2010

40. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review

Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side-effects after major surgery: a systematic review Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side (...) side-effects after major surgery: a systematic review. Health Technology Assessment 2010; 14(17): 1-94 Authors' conclusions Study found no strong case for routine addition of paracetamol, non-steroidal anti-inflammatory drugs or cyclo-oxygenase inhibitors to patient-controlled administered morphine to reduce morphine consumption and associated adverse effects in the 24 hours following major surgery Project page URL URL for DARE abstract INAHTA brief and checklist Indexing Status Subject indexing

Health Technology Assessment (HTA) Database.2010